Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study
- 13 January 1998
- journal article
- clinical trial
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 8 (1) , 67-75
- https://doi.org/10.1016/s0924-977x(97)00079-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled TrialDementia and Geriatric Cognitive Disorders, 1996
- Comparison of the Pharmacokinetics of E2020, A New Compound for Alzheimer's Disease, in Healthy Young and Elderly SubjectsThe Journal of Clinical Pharmacology, 1993
- A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's DiseaseNew England Journal of Medicine, 1992
- Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine hydrochloride (E2020) and related compoundsBioorganic & Medicinal Chemistry Letters, 1992
- Mild senile dementia of the Alzheimer type. 4. Evaluation of interventionAnnals of Neurology, 1992
- Conformational analyses and molecular-shape comparisons of a series of indanone-benzylpiperidine inhibitors of acetylcholinesteraseJournal of Medicinal Chemistry, 1992
- Quantitative structure-activity relationship. QSAR, analyses of the substituted indanone and benzylpiperidine rings of a series of indanone-benzylpiperidine inhibitors of acetylcholinesteraseJournal of Medicinal Chemistry, 1992
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982